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Body Mass Index and Weight
Gain in Pregnant Women
With HIV: A National Study in
Italy
Despite the growing number of human
immunodeficiency virus (HIV)–infected
women who are pregnant or planning a
pregnancy, there is limited information
on body weight status and weight gain
in pregnancy in this population. The
issue is relevant, because inadequate or
excessive body mass index (BMI) and
weight gain in pregnancy are risk factors
for adverse pregnancy outcomes in the
general population [1, 2], and may in-
crease the risk of some events commonly
observed among pregnant women with
HIV, such as preterm delivery or glucose
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metabolism abnormalities [3, 4]. We in-
vestigated BMI status, weight gain in
pregnancy, and gestational outcomes
within the Italian National Program on
Surveillance on Antiretroviral Treatment
in Pregnancy, a large cohort study of
pregnant women with HIV [5].
All information was taken from clini-
cal records. Given the variability in
screening procedures and diagnostic cri-
teria for gestational diabetes during the
10-year interval considered, we used a
restrictive definition that considered
among the recent American Diabetes
Association criteria [6] only fasting
plasma glucose levels >92 mg/dL at 20–
28 weeks. Preterm delivery was defined
as delivery before 37 completed weeks of
gestation and low birthweight as neo-
nates weighing <2500 g. Cesarean deliv-
ery was considered nonelective if
performed after the rupture of mem-
branes, the onset of labor, or both. Birth
defects were defined according to the
Antiretroviral Pregnancy Registry crite-
ria [7], and sex-adjusted and gestational
age–adjusted birthweight percentiles were
calculated according to Italian reference
standards [8]. The associations between
potentially predictive variables and preg-
nancy outcomes were assessed using
univariate logistic regression, and were
expressed as odds ratios (ORs) and 95%
confidence intervals (CIs).
Data were extracted from the study
database on 25 July 2012. At this time,
736 pregnancies with live births had
available information on BMI and weight
gain in pregnancy and were therefore
analyzed. The BMI categories (under-
weight, normal, overweight, obese) of
the population studied and the pregnan-
cy weight gain for each BMI category,
including proportions of women meeting
the Institute of Medicine recommenda-
tions for weight gain in pregnancy [9],
are shown in Table 1.
Although most of the women (69.4%)
had a normal BMI at start of pregnancy,
only 37% had an adequate weight gain
during pregnancy. Inadequate body
weight gain was more common (44.8%)
than excessive weight gain (18.2%), but
40% of overweight women and 50% of
obese women had an excessive weight
gain in pregnancy, with about 9% of the
women in these categories gaining >18
kg during pregnancy (Table 1).
Only 1.9% of the women had a
vaginal delivery; elective and nonelective
cesarean deliveries accounted for 81.3%
and16.7%ofdeliveries, respectively.Com-
pared to underweight/normal women,
overweight/obese women had similar oc-
currences of preterm delivery (23.4% vs
22.7%, P = .871), significantly lower rates
of low birthweight (14.2% vs 24.2%,
P = .007) and nonelective cesarean deliv-
eries (11.7% vs 18.3%, P = .042), and a
significantly higher occurrence of fasting
plasma glucose >92 mg/dL at 20–28
weeks (12.1% vs 6.6%, P = .027), hyper-
tension during pregnancy (6.4% vs 2.7%,
P = .019), and gestational age–adjusted
birthweight >90th percentile (15.5% vs
5.0%, P < .001). Complications of deliv-
ery, major birth defects, and HIV trans-
mission were similar between the 2
groups (7.3% vs 7.6%, P = .881; 2.6% vs
3.5%, P = .589; and 0.8% vs 0.5%,
P = .661, respectively).
Table 1. Body Mass Index Status at Conception and Weight Gain in Pregnancy
BMI (kg/m2) Status at Conception
Characteristic
Underweight
(<18.5)
Normal
(18.5–24.9)
Overweight
(25.0–29.9)
Obese
(≥ 30) All
No. (%) 54 (7.3) 511 (69.4) 125 (17.0) 46 (6.3) 736 (100)
Recommended total weight gain
during pregnancya, kg
12.5–18.0 11.5–16.0 7.0–11.5 5.0–9.0 …
Weight gain during pregnancy, kg,
mean (SD)
12.5 (4.2) 11.6 (4.1) 10.5 (5.5) 9.1 (7.3) 11.4 (4.6)
Weight gain per wk, kg, mean (SD) 0.339 (0.12) 0.315 (0.11) 0.283 (0.14) 0.246 (0.20) 0.308 (0.12)
Weight gain during pregnancy
Inadequate 26 (48.1) 265 (51.9) 29 (23.2) 10 (21.7) 330 (44.8)
Adequate 25 (46.3) 188 (36.8) 46 (36.8) 13 (28.3) 272 (37.0)
Excessive 3 (5.6) 58 (11.4) 50 (40.0) 23 (50.0) 134 (18.2)
Weight gain <0.100 kg/wk 1 (1.9) 4 (0.8) 10 (8.0) 10 (21.7) 25 (3.4)
Weight gain >0.400 kg/wk 16 (29.6) 97 (19.0) 20 (16.0) 10 (21.7) 143 (19.4)
Weight gain <5 kg 1 (1.9) 10 (2.0) 14 (11.2) 10 (21.7) 35 (4.8)
Weight gain >18 kg 3 (5.6) 30 (5.9) 11 (8.8) 4 (8.7) 48 (6.5)
Data are No. (%) unless otherwise specified.
Abbreviations: BMI, body mass index; SD, standard deviation.
a Institute of Medicine recommendations [9].
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An inadequate weight gain during
pregnancy was associated with an in-
creased risk of nonelective cesarean deliv-
ery (OR, 1.589 [95% CI, 1.077–2.346],
P = .020). Excessive weight gain during
pregnancy was not associated with either
hypertension (OR, 1.364 [95% CI, .537–
3.465], P = .514) or 20–28 week glucose
level of >92 mg/dL (OR, 0.841 [95% CI,
.399–1.772], P = .648), but was signifi-
cantly associated with birthweight >90th
percentile (OR, 2.271 [95% CI, 1.229–
4.195], P = .009), and appeared to be pro-
tective against low birthweight (OR,
0.544 [95% CI, .323–.918], P = .023) and
birthweight <10th percentile (OR, 0.297
[95% CI, .117–.752], P = .007).
Our data show that almost one-
quarter of pregnant women with HIV
are overweight or obese at the beginning
of pregnancy, and that women in these
groups have a significantly increased oc-
currence of diabetes and hypertension in
pregnancy. The risks of low birthweight
and nonelective cesarean delivery were
higher in the underweight/normal BMI
categories. Consistent with data from the
general population [10], only 37% of
pregnant women with HIV had an ade-
quate weight gain in pregnancy. Exces-
sive weight gain during pregnancy was
particularly frequent among overweight
and obese women. Inadequate weight
gain was associated with nonelective ce-
sarean delivery, and excessive weight gain
with large-for-gestational-age infants. BMI
and weight gain represent modifiable risk
factors that should be adequately identified
and corrected in order to reduce adverse
pregnancy outcomes in this population.
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